Comorbidities in Chronic Kidney Disease (CKD)
With a mean worldwide prevalence of 13%, chronic kidney disease imposes a massive health burden on our society. In addition to reduced kidney function, patients with chronic kidney disease increasingly suffer from cardiovascular diseases affecting the heart and vasculature. Cardiovascular diseases a...
Gardado en:
| Formato: | Online |
|---|---|
| Idioma: | inglés |
| Publicado: |
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Acceso en liña: | ONIX_20210501_9783039366682_167 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
| _version_ | 1869529101171163136 |
|---|---|
| collection | Directory of Open Access Books |
| description | With a mean worldwide prevalence of 13%, chronic kidney disease imposes a massive health burden on our society. In addition to reduced kidney function, patients with chronic kidney disease increasingly suffer from cardiovascular diseases affecting the heart and vasculature. Cardiovascular diseases account for around half of the deaths of patients with advanced chronic kidney disease. However, therapeutic options are highly insufficient. The pathological mechanisms that underlie increased cardiovascular risk in patients with chronic kidney disease remain largely unknown. This Special Issue provides insights into comorbidities in CKD patients, mainly focused on increased cardiovascular risk, and summarizes current knowledge of underlying pathophysiological mechanisms. |
| format | Online |
| id | doab-20.500.12854ir-68421 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-684212024-03-31T13:10:05Z Comorbidities in Chronic Kidney Disease (CKD) Jankowski, Joachim Noels, Heidi arterial stiffness carotid–femoral pulse wave velocity hemodialysis p-cresyl sulfate uremic toxins arterial calcification lipid metabolism inflammation coagulation endothelial dysfunction epigenetics chronic kidney disease uremic cardiopathy left ventricular hypertrophy phosphate PTH FGF23 klotho sclerostin chronodisruption chronodisruptor circadian rhythm internal clock uremia uremic cardiomyopathy organ crosstalk cardiorenal syndrome left-ventricular hypertrophy heart failure cardiac fibrosis cardiovascular disease vascular calcification experimental rodent models FGFG23 Klotho Wnt/β-catenin CKD parathyroid hormone secondary hyperparathyroidism uremic toxin ageing end-stage kidney disease premature ageing senescence bone gut cardiovascular CKD–MBD comorbidity fibrosis calcification thema EDItEUR::M Medicine and Nursing With a mean worldwide prevalence of 13%, chronic kidney disease imposes a massive health burden on our society. In addition to reduced kidney function, patients with chronic kidney disease increasingly suffer from cardiovascular diseases affecting the heart and vasculature. Cardiovascular diseases account for around half of the deaths of patients with advanced chronic kidney disease. However, therapeutic options are highly insufficient. The pathological mechanisms that underlie increased cardiovascular risk in patients with chronic kidney disease remain largely unknown. This Special Issue provides insights into comorbidities in CKD patients, mainly focused on increased cardiovascular risk, and summarizes current knowledge of underlying pathophysiological mechanisms. 2021-05-01T15:09:20Z 2021-05-01T15:09:20Z 2021 book ONIX_20210501_9783039366682_167 9783039366682 9783039366699 https://directory.doabooks.org/handle/20.500.12854/68421 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/3437 https://mdpi.com/books/pdfview/book/3437 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03936-669-9 10.3390/books978-3-03936-669-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783039366682 9783039366699 184 Basel, Switzerland open access |
| spellingShingle | arterial stiffness carotid–femoral pulse wave velocity hemodialysis p-cresyl sulfate uremic toxins arterial calcification lipid metabolism inflammation coagulation endothelial dysfunction epigenetics chronic kidney disease uremic cardiopathy left ventricular hypertrophy phosphate PTH FGF23 klotho sclerostin chronodisruption chronodisruptor circadian rhythm internal clock uremia uremic cardiomyopathy organ crosstalk cardiorenal syndrome left-ventricular hypertrophy heart failure cardiac fibrosis cardiovascular disease vascular calcification experimental rodent models FGFG23 Klotho Wnt/β-catenin CKD parathyroid hormone secondary hyperparathyroidism uremic toxin ageing end-stage kidney disease premature ageing senescence bone gut cardiovascular CKD–MBD comorbidity fibrosis calcification thema EDItEUR::M Medicine and Nursing Comorbidities in Chronic Kidney Disease (CKD) |
| title | Comorbidities in Chronic Kidney Disease (CKD) |
| title_full | Comorbidities in Chronic Kidney Disease (CKD) |
| title_fullStr | Comorbidities in Chronic Kidney Disease (CKD) |
| title_full_unstemmed | Comorbidities in Chronic Kidney Disease (CKD) |
| title_short | Comorbidities in Chronic Kidney Disease (CKD) |
| title_sort | comorbidities in chronic kidney disease ckd |
| topic | arterial stiffness carotid–femoral pulse wave velocity hemodialysis p-cresyl sulfate uremic toxins arterial calcification lipid metabolism inflammation coagulation endothelial dysfunction epigenetics chronic kidney disease uremic cardiopathy left ventricular hypertrophy phosphate PTH FGF23 klotho sclerostin chronodisruption chronodisruptor circadian rhythm internal clock uremia uremic cardiomyopathy organ crosstalk cardiorenal syndrome left-ventricular hypertrophy heart failure cardiac fibrosis cardiovascular disease vascular calcification experimental rodent models FGFG23 Klotho Wnt/β-catenin CKD parathyroid hormone secondary hyperparathyroidism uremic toxin ageing end-stage kidney disease premature ageing senescence bone gut cardiovascular CKD–MBD comorbidity fibrosis calcification thema EDItEUR::M Medicine and Nursing |
| topic_facet | arterial stiffness carotid–femoral pulse wave velocity hemodialysis p-cresyl sulfate uremic toxins arterial calcification lipid metabolism inflammation coagulation endothelial dysfunction epigenetics chronic kidney disease uremic cardiopathy left ventricular hypertrophy phosphate PTH FGF23 klotho sclerostin chronodisruption chronodisruptor circadian rhythm internal clock uremia uremic cardiomyopathy organ crosstalk cardiorenal syndrome left-ventricular hypertrophy heart failure cardiac fibrosis cardiovascular disease vascular calcification experimental rodent models FGFG23 Klotho Wnt/β-catenin CKD parathyroid hormone secondary hyperparathyroidism uremic toxin ageing end-stage kidney disease premature ageing senescence bone gut cardiovascular CKD–MBD comorbidity fibrosis calcification thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20210501_9783039366682_167 |